Primary Site >> Colorectal Cancer
Gene >> BAMBI
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. PMID: 14660579 |
Ref: Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. PMID: 16380080 |
Ref: Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. PMID: 18756595 |
Ref: A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. PMID: 19328798 |
Ref: Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression. PMID: 19998449 |
Ref: miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. PMID: 22180714 |
Ref: Knockdown of BAMBI inhibits beta-catenin and transforming growth factor beta to suppress metastasis of gastric cancer cells. PMID: 24912656 |
Ref: New Wnt/beta-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals. PMID: 26156959 |
Ref: Inhibition of BAMBI reduces the viability and motility of colon cancer via activating TGF-beta/Smad pathway in vitro and in vivo. PMID: 29085481 |
Ref: Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library. PMID: 29719626 Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). PMID: 29786110 |